Home » Topics » BioWorld Science

BioWorld Science
RSS

BridGene Biosciences divulges YAP1/TEAD interaction inhibitors

Jan. 28, 2022

Pfizer patents new JAK inhibitors

Jan. 28, 2022

Beta-elemene NO derivatives demonstrate potent antiglioma activity in vivo

Jan. 28, 2022

Novel nonviral engineered BAFF-CAR T cells show efficacy in multiple B-cell cancer models

Jan. 28, 2022

Sophoridine derivatives show improved potency against triple-negative breast cancer

Jan. 28, 2022

Loperamide shows antitumoral activity in TET2-mutated AML

Jan. 28, 2022

Low penetrance of deleterious genetic variants observed in large cohorts

Jan. 28, 2022

Structure-based psychedelic analogue discovery reported

Jan. 28, 2022

Somatic tissue engineering gives insights into ovarian cancer

Jan. 27, 2022

IL-2Rbeta agonist MDNA-11 shows promising results in preclinical cancer models

Jan. 27, 2022

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...